When given to patients newly diagnosed with aggressive brain cancer, the drug bevacizumab reduces the density of blood vessels in tumors but... Read more
You have been sent this Keio Research Highlights e-alert because you have subscribed to it. You can discontinue your e-alert subscription at any time by going to the unsubscribe page.